UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

Clinical pharmacology and therapeutics, 2018-04, Vol.103 (4), p.574-581

2018

Volltextzugriff (PDF)

Recommendations for HLA‐B15:02 and HLA‐A31:01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions

Epilepsia (Copenhagen), 2014-04, Vol.55 (4), p.496-506

2014

Volltextzugriff (PDF)

Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity

British journal of clinical pharmacology, 2016-09, Vol.82 (3), p.683-695

2016

Volltextzugriff (PDF)

All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity

PloS one, 2022-11, Vol.17 (11), p.e0276541

2022

Volltextzugriff (PDF)

Paediatric oral formulations: Why don't our kids have the medicines they need?

British journal of clinical pharmacology, 2022-10, Vol.88 (10), p.4337-4348

2022

Volltextzugriff (PDF)

The incidence of symptomatic osteonecrosis after allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia – controversy on dexamethasone as a risk factor

British journal of haematology, 2019-06, Vol.185 (5), p.958-959

2019

Volltextzugriff (PDF)

Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity

Circulation (New York, N.Y.), 2022-01, Vol.145 (4), p.279-294

2022

Volltextzugriff (PDF)

Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings

Annual review of pharmacology and toxicology, 2021-01, Vol.61 (1), p.65-84

2021

Volltextzugriff (PDF)

Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence

The Journal of infectious diseases, 2021-02, Vol.223 (3), p.355-358

2021

Volltextzugriff (PDF)

Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery

JAMA ophthalmology, 2017-04, Vol.135 (4), p.363

2017

Volltextzugriff (PDF)

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1422-1428

2012

Volltextzugriff (PDF)

Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study

Journal of clinical psychopharmacology, 2017-02, Vol.37 (1), p.102-104

2017

Volltextzugriff (PDF)

Pharmacogenomics in Pediatric Oncology: Mitigating Adverse Drug Reactions While Preserving Efficacy

Annual review of pharmacology and toxicology, 2021-01, Vol.61 (1), p.679-699

2021

Volltextzugriff (PDF)

RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy

Cell stem cell, 2021-12, Vol.28 (12), p.2076-2089.e7

2021

Volltextzugriff (PDF)

More codeine fatalities after tonsillectomy in North American children

Pediatrics (Evanston), 2012-05, Vol.129 (5), p.e1343-e1347

2012

Volltextzugriff (PDF)

Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review

Therapeutic drug monitoring, 2024-09

2024

Volltextzugriff (PDF)

Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines

PloS one, 2017-04, Vol.12 (4), p.e0175711

2017

Volltextzugriff (PDF)

The Role of Pharmacogenomics in Rare Diseases

Drug safety, 2024-06, Vol.47 (6), p.521-528

2024

Volltextzugriff (PDF)

Fluoroquinolone Use and Risk of Carpal Tunnel Syndrome: A Pharmacoepidemiologic Study

Clinical infectious diseases, 2017-08, Vol.65 (4), p.684-686

2017

Volltextzugriff (PDF)

The cumulative incidence of cisplatin‐induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments

Cancer, 2022-01, Vol.128 (1), p.169-179

2022

Volltextzugriff (PDF)

Association of Postoperative Topical Prostaglandin Analog or Beta-Blocker Use and Incidence of Pseudophakic Cystoid Macular Edema

Journal of glaucoma, 2018-05, Vol.27 (5), p.402-406

2018

Volltextzugriff (PDF)

COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials

Canadian journal of physiology and pharmacology, 2021-06, Vol.99 (6), p.577-588

2021

Volltextzugriff (PDF)

Pharmacogenomic testing in paediatrics: Clinical implementation strategies

British journal of clinical pharmacology, 2022-10, Vol.88 (10), p.4297-4310

2022

Volltextzugriff (PDF)

Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity

Therapeutic drug monitoring, 2023-06, Vol.45 (3), p.337

2023

Volltextzugriff (PDF)

1 – 25 von 342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(241)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(340)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

Recommendations for HLA‐B15:02 and HLA‐A31:01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions

Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity

All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity

Paediatric oral formulations: Why don't our kids have the medicines they need?

The incidence of symptomatic osteonecrosis after allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia – controversy on dexamethasone as a risk factor

Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity

Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings

Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence

Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes

Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study

Pharmacogenomics in Pediatric Oncology: Mitigating Adverse Drug Reactions While Preserving Efficacy

RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy

More codeine fatalities after tonsillectomy in North American children

Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review

Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines

The Role of Pharmacogenomics in Rare Diseases

Fluoroquinolone Use and Risk of Carpal Tunnel Syndrome: A Pharmacoepidemiologic Study

The cumulative incidence of cisplatin‐induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments

Association of Postoperative Topical Prostaglandin Analog or Beta-Blocker Use and Incidence of Pseudophakic Cystoid Macular Edema

COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials

Pharmacogenomic testing in paediatrics: Clinical implementation strategies

Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity

Suchergebnisse filtern